Dr Sanjuan-Nandin is an alumnus of University College London and is currently a Senior Scientist at Cancer リサーチ UK. Coming from a strong background in translational immunology, her main interest is the research and development of new strategies in immunotherapy. Her research career started with her PhD プロジェクト in cellular and molecular immunology, which led to strong interest in antibody drug development.
ユニバーシティ・カレッジ・ロンドンでのポスドク時代には、細胞免疫療法、特に多発性骨髄腫の免疫療法に取り組んだ。このプロジェクトは、彼女のこれまでの体液性免疫療法の経験を補完し、がん免疫療法の知識を広げるものでした。
Dr Sanjuan-Nandin has not only rich academic experience but commendable インダストリー experience as well. Her position at UCB Pharma gave her the opportunity to apply her previous academic experience in a very innovative project to discover new cancer antigens harnessing the むりのない immune response against tumours. She returned to academia (Imperial College London) where she gained experience in working with recombinant antibodies, which complemented her knowledge of monoclonal antibodies.Her work was focussed on the expression and purification of antibody fragments (scFv) and conjugations to photo-sensitizers to improve the specificity of photodynamic therapy (PDT).
Dr Sanjuan-Nandin was appointed at Cancer Research UK in 2011 to apply her expertise in antibody development into a new platform to obtain human monoclonal antibodies from human B セル stimulated in vitro. The success of this unique platform led to the establishment of a the spin-off company: Blink Therapeutics. She currently investigating the application of this strategy in ワクチン development.
Specializations: Biochemistry, Molecular Biology, Immunoassay, Biotechnology, Immunology
連絡を取りたい サンジュアン-ナンディン博士 プロジェクトをお考えですか？www.kolabtree.com にご登録ください。
Kolabtreeは、世界中の企業がオンデマンドで専門家を雇用できるよう支援します。私たちのフリーランサーは、企業が研究を公開するのを助けてきました。 書類製品開発、データ解析など、さまざまな業務に対応します。1分ほどで、お客様のご要望をお聞かせいただき、専門家によるお見積りを無料でお受けしています。
